Who do I call for instrument service during the integration?
All worldwide customer service and support inquiries for Molecular Device's products should continue to be through the regional Molecular Devices contacts and channels. To check the customer support representatives in your region visit http://www.moleculardevices.com/pages/contact.html.
Will MDS Inc. honor existing and future service contracts and warranties?
Yes, MDS Inc. will continue to offer and support via the Molecular Devices worldwide customer support organization including all existing and future service warranties and agreements.
Who do I call to place and order?
All orders for Molecular Devices products, including Universal Imaging and Axon Instruments should be through the regional Molecular Devices sales representatives. To check the sales office in your region visit http://www.moleculardevices.com/pages/contact.html.
Will Molecular Devices continue to offer the same products?
Molecular Devices will continue to offer a full range of life science and drug discovery products.
What is MDS Inc.?
MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that their customers need for the development of drugs and diagnosis and treatment of disease. They are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS, Inc. is composed of three main businesses: MDS Pharma Services, MDS Sciex and MDS Nordion. http://www.mdsinc.com.
Will Molecular Devices continue to exist?
MDS Inc. plans to create a new business unit, which will include the MDS Sciex and Molecular Devices businesses. This new business unit will be led by the current President of MDS Sciex, Andy Boorn PhD.
When will the deal be closed?
It is expected that the merger will be completed in the second quarter of the calendar year 2007.
